ARCHIVES

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

Foundation Supports Chicago Researchers

September 10, 1993

Gene Therapy Experiments Get RDAC Okay

August 10, 1990

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974